Femina Flora Oral II
Femina Flora Oral II, NPN 80116921: natural health product licensed in Canada. Medicinal ingredients: Bifidobacterium breve, Lactobacillus crispatus, Lactobacillus acidophilus, Lacticaseibacillus rhamnosus.
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Bifidobacterium breve Source : UB8674 | 2 Milliards d'UFC | Not calculated |
| Bifidobacterium breve Source : Bifidobacterium breve - Cellule entière | 2 Milliards d'UFC | Not calculated |
| Lactobacillus crispatus Source : UB4719 | 0.75 Milliards d'UFC | Not calculated |
| Lactobacillus acidophilus Source : LA-14 | 0.3 Milliards d'UFC | Not calculated |
| Lactobacillus acidophilus Source : Lactobacillus acidophilus - Cellule entière | 0.3 Milliards d'UFC | Not calculated |
| Lacticaseibacillus rhamnosus Source : GG | 0.3 Milliards d'UFC | Not calculated |
| Lactobacillus acidophilus Source : UB5997 | 5.25 Milliards d'UFC | Not calculated |
| Lactobacillus acidophilus Source : Lactobacillus acidophilus - Cellule entière | 5.25 Milliards d'UFC | Not calculated |
| Lactiplantibacillus plantarum Source : UB2783 | 8 Milliards d'UFC | Not calculated |
| Lactiplantibacillus plantarum Source : Lactiplantibacillus Plantarum - Cellule entière | 8 Milliards d'UFC | Not calculated |
| Lactobacillus johnsonii Source : UB3394 | 0.75 Milliards d'UFC | Not calculated |
| Lacticaseibacillus casei Source : UB1499 | 12 Milliards d'UFC | Not calculated |
| Lacticaseibacillus rhamnosus Source : UB5115 | 19 Milliards d'UFC | Not calculated |
Non-medicinal ingredients
Acide oléique, Xylooligosaccharides, Alginate de sodium, Éthylcellulose, Fécule de pomme de terre, Triglycérides à chaîne moyenne, Trehalose, Arabinogalactane, Inuline, Hypromellose, Acide stéarique, Eau purifiée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | minimum: 1 Capsule ; maximum: 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
A factor in the maintenance of good health. Antioxidant for good health. Contributes to maintaining general health. For maintaining general health. Helps (to) maintain/support immune function. Helps in collagen formation to maintain healthy bones, cartilage, teeth and/or gums. Helps in connective tissue formation. Helps in the development and maintenance of bones, cartilage, teeth and/or gums and in connective tissue formation. Helps in the development and maintenance of bones, cartilage, teeth and/or gums. Helps in wound healing and connective tissue formation. Helps in wound healing. Helps to maintain the body¿s ability to metabolize nutrients. Helps with immune function. Maintains good health. Source of/An antioxidant for the maintenance of good health. Source of/An antioxidant that helps fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Supports good health. Vitamin supplement. Could promote a favorable gut flora. Helps support intestinal/gastrointestinal health. Source of Probiotics. Source of vitamin, a factor/factors in the maintenance of good health. Source of vitamin, a factor/factors in normal growth and development. Source of vitamin to support biological functions which play a key role in the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contra-Indications
Do not use this product if you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment).
- Cautions and Warnings
Consult a health care practitioner prior to use if you have fever, vomiting, bloody diarrhoea or severe abdominal pain. Stop use and consult a health care practitioner if symptoms of digestive upset (e.g. diarrhea) occur, worsen and/or persists beyond 3 days.
Product record
- Licence holder
- New Roots Herbal Inc.
- NPN or DIN-HM
- 80116921
- Status
- Active licence
- Licence date
- 4 March 2022
- Revision date
- 31 May 2022
- Form
- Capsule, libération retardée
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
Source
Official Health Canada record, licence 80116921
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Femina Flora Oral II (New Roots Herbal Inc.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80116921-femina-flora-oral-ii, updated 31 May 2022.